Skip to content
Baltimore News Journal – Lifestyle
Author:
Vect-Horus
Vect-Horus announces collaboration and license option agreement with Servier to develop targeted oligonucleotide therapeutics for rare CNS diseases
June 30, 2026
Vect-Horus appoints Claudia Fromond as new Director of R&D
March 10, 2026